最新 Form 144 申報
公司的高階主管、董事與其他關係人要賣出受限制股票或控制股份，而且三個月內預計賣出超過 5,000 股或 5 萬美元時，下單時要交 Form 144。它是預計賣出的通知；高階主管、董事實際賣出之後，會再申報 Form 4。13D、13G 與 Form 144 是什麼
Form 144 申報
由新到舊。有 Form 144/A 修正的申報只列修正後的那一份。
近 365 天的申報（依美東日期）。
本站的 Form 144 申報：2023/1/4 到 2026/10/2。
市值明顯填錯的申報不列在這裡，也不算進合計；公司的頁面照樣列出並加註。判斷方式是把市值除以股數，得到的每股價格遠高於這家公司在預計賣出日前後的 Form 4 成交價與 13F 持股的價格，就當成填錯。
- 申報份數
- 80
- 預計賣出市值
- $1.05 億
- 賣方
- 11
- 公司
- 1
- 依 10b5-1 計畫
- 65
| 公司 | 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | 2026/9/1716:35 ET | Eric Dube董事 · 高階主管 | 10.8 萬 | $688.7 萬 | 2026/9/1710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1716:30 ET | Peter Heerma高階主管 | 8,282 | $52.6 萬 | 2026/9/1710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1616:33 ET | William Rote高階主管 | 11.3 萬 | $705.4 萬 | 2026/9/1610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1616:32 ET | Peter Heerma高階主管 | 17.3 萬 | $1,080 萬 | 2026/9/1610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1616:30 ET | Eric Dube董事 · 高階主管 | 19.6 萬 | $1,224 萬 | 2026/9/1610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1516:44 ET | Sandra Calvin高階主管 | 5,375 | $35.4 萬 | 2026/9/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1516:44 ET | Christopher Cline高階主管 | 5.05 萬 | $332.3 萬 | 2026/9/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1516:43 ET | Elizabeth Reed高階主管 | 3.96 萬 | $260.4 萬 | 2026/9/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1516:42 ET | Eric Dube董事 · 高階主管 | 9.57 萬 | $629.4 萬 | 2026/9/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1516:41 ET | Peter Heerma高階主管 | 10.2 萬 | $672.3 萬 | 2026/9/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1516:35 ET | William Rote高階主管 | 9.62 萬 | $632.9 萬 | 2026/9/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1516:24 ET | Jula Inrig高階主管 | 4.47 萬 | $293.9 萬 | 2026/9/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/9/1016:38 ET | Jeffrey Meckler董事 | 2.00 萬 | $132.4 萬 | 2026/9/1010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/8/1816:24 ET | Gary Lyons董事 | 5,000 | $31.8 萬 | 2026/8/1810b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/8/1716:31 ET | Gary A Lyons董事 | 5,000 | $31.1 萬 | 2026/8/1710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/6/1216:05 ET | Roy Baynes董事 | 4,500 | $22.5 萬 | 2026/6/1210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/6/1212:20 ET | Coughlin Timothy董事 | 1.00 萬 | $50.0 萬 | 2026/6/1210b5-1 | Wells Fargo Clearing Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/1512:51 ET | Coughlin Timothy董事 | 3,250 | $14.1 萬 | 2026/5/1510b5-1 | Wells Fargo Clearing Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/616:03 ET | Christopher Cline高階主管 | 310 | $1.36 萬 | 2026/5/610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/616:03 ET | Elizabeth Reed高階主管 | 2,076 | $9.12 萬 | 2026/5/610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/616:02 ET | Jula Inrig高階主管 | 311 | $1.37 萬 | 2026/5/610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/609:55 ET | Dube Eric M高階主管 | 2.25 萬 | $98.9 萬 | 2026/5/610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/609:37 ET | Rote William E.高階主管 | 2,763 | $12.1 萬 | 2026/5/610b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/519:48 ET | Christopher Cline高階主管 | 2,181 | $10.2 萬 | 2026/5/5 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/519:32 ET | Elizabeth E. Reed高階主管 | 2,174 | $10.1 萬 | 2026/5/5 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/519:31 ET | Jula Inrig高階主管 | 2,174 | $10.1 萬 | 2026/5/5 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/519:31 ET | Peter Heerma高階主管 | 2,174 | $10.1 萬 | 2026/5/5 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/516:53 ET | Roy Baynes董事 | 4,500 | $21.0 萬 | 2026/5/510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/416:04 ET | Elizabeth Reed高階主管 | 2.00 萬 | $90.0 萬 | 2026/5/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/416:04 ET | Jeffrey Meckler董事 | 8,000 | $36.0 萬 | 2026/5/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/416:03 ET | Jula Inrig高階主管 | 2.00 萬 | $90.0 萬 | 2026/5/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/5/116:15 ET | Roy Baynes董事 | 9,750 | $43.1 萬 | 2026/5/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/2210:36 ET | Rote William E.高階主管 | 9,100 | $35.6 萬 | 2026/4/2210b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1516:16 ET | Dube Eric M高階主管 | 6.40 萬 | $263.0 萬 | 2026/4/1510b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1516:15 ET | Elizabeth Reed高階主管 | 6,785 | $28.4 萬 | 2026/4/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1516:14 ET | Christopher Cline高階主管 | 1,014 | $4.32 萬 | 2026/4/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1516:13 ET | Jula Inrig高階主管 | 1,018 | $4.34 萬 | 2026/4/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1421:17 ET | Elizabeth E. Reed高階主管 | 7,215 | $30.3 萬 | 2026/4/14 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1420:53 ET | Jula Inrig高階主管 | 7,215 | $30.3 萬 | 2026/4/14 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1420:47 ET | Peter Heerma高階主管 | 7,215 | $30.3 萬 | 2026/4/14 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1420:40 ET | Christopher Cline高階主管 | 7,239 | $30.4 萬 | 2026/4/14 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1416:27 ET | Gary A Lyons高階主管 | 8,000 | $24.6 萬 | 2026/4/1410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1416:20 ET | Christopher Cline高階主管 | 9 | $369.63 | 2026/4/1410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1416:19 ET | Elizabeth Reed高階主管 | 3.75 萬 | $154.0 萬 | 2026/4/1410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1416:09 ET | Roy Baynes董事 | 3.27 萬 | $135.2 萬 | 2026/4/1410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1416:02 ET | Sandra Calvin高階主管 | 2.20 萬 | $90.3 萬 | 2026/4/1410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/1320:11 ET | Christopher Cline高階主管 | 65 | $1,875.25 | 2026/4/13 | Morgan Stanley Smith Barney | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/616:06 ET | Roy Baynes董事 | 1.00 萬 | $33.0 萬 | 2026/4/610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/116:13 ET | Dube Eric M高階主管 · 董事 | 6.00 萬 | $185.6 萬 | 2026/4/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| TVTXTravere Therapeutics, Inc. | 2026/4/116:06 ET | Elizabeth Reed高階主管 | 1.00 萬 | $30.0 萬 | 2026/4/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |